Agoracom Blog

#Wearables For #Mhealth Apps: The Future Of The Healthcare Industry SPONSOR: CardioComm Solutions $EKG.ca – $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 3:00 PM on Monday, March 2nd, 2020

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

Wearables For Mhealth Apps: The Future Of The Healthcare Industry

  • While the benefits of mHealth apps and wearables among the common users are well known, the benefits of its use among healthcare professionals are still unknown
  • There are various ways health wearables are changing the healthcare industry, streamlining diagnosis and treatment

By: Olivia Taylor

There’s a new technology trend in the market every day. Some of these succeed, while some of these fail to make their mark. But what happens when two very successful technology trends come together?

When the wearable technology started to enter the market, not many people gave it a second thought. Whether it’s a Bluetooth headphone, Google glasses or Apple watch. The ordinary “not-so-tech-savvy” users were not very enthusiastic about investing in these devices until they connected with another major trend in the market, the mHealth apps.

Due to the emergence of smartphones, users have been using mHealth apps for a long time already. These usages were limited to recording their health details and whatnot. But with the wearable technology, they now have a hands-on way of tracking various aspects of their health in real-time. Whether it is their blood pressure or heart rate per minute, with the integration of wearable technology in mHealth apps, the users now have the perfect way of keeping track of their health.

It will, however, be wrong of us to assume that mHealth app wearables are only limited to modern fitness bands such as Fitbits and Mi bands. Wearable devices for mHealth apps have crossed the boundaries of simply keeping track of fitness and reached healthcare professionals to help them with various complex medical diagnoses and problems. What are these problems? Let’s have a look.

Wearable Trends In mHealth App: How It Helps The Professionals?

While the benefits of mHealth apps and wearables among the common users are well known, the benefits of its use among healthcare professionals are still unknown. There are various ways health wearables are changing the healthcare industry, streamlining diagnosis and treatment.

Here are a few examples of how the emerging technology of wearables in mHealth application are helping out the professionals in the field.

Increasing Efficiency During Surgery

If we are talking about the benefits of wearables in the healthcare industry, we need to start with the increased efficiency during surgery. Performing surgery on the human body is a complicated enough procedure, but now the integration of wearables is helping the surgeons to perform even the most complicated surgeries with precision.

While previously the approach to surgery was an “Open” approach, today thanks to wearable and mHealth tech, the surgeons can apply the minimally invasive methods of performing surgery. This way they can prevent a lot of blood loss, shorter recovery time for the patients and fewer chances of infections.

Whether we are talking about the development of robotic wearable arm for surgeries or the simple application of Google Glasses, the wearable tech in mHealth apps are surely making the otherwise complex field of surgeries a lot easier to navigate.

Wearable IoT in the Healthcare Industry

IoT is already an extremely popular technology trend in the market. And when you add that to the wearable mHealth trends in the healthcare industry, you have plenty of efficient applications of wearable IoT in healthcare.

Besides the more obvious use of IoT to locate medical instruments throughout the building, the wearable IoT devices are helping the medical professionals to locate doctors within seconds during an emergency. These devices are also helping with the treatment of patients, as it is evident from the popularity of smart continuous glucose monitors and connected inhalers. With these connected devices it is easier for the medical professionals to not only diagnose the patient but treat them with accuracy.

The wearable IoT devices in the healthcare industry have proven that the amalgamation of technology with the healthcare industry is going to be extremely beneficial for both the patients as well as the doctors.

Wearable Biosensors

One of the most futuristic applications of wearable technology for mHealth apps is wearable biosensors. These small sensors are capable of providing continuous physiological information through non-invasive methods. With these sensors, healthcare professionals can measure the biochemical markers in biofluids like sweat, blood, tears, saliva, etc to keep track of the patient’s health and help the physicians to provide better treatment.

Not just for healthcare, these wearable sensors are being used by the sportspeople and military as well. With Biosensors like these, the military could actually monitor the health of their troops on the field. The medical experts can keep track of any chemical or infectious agent the soldiers can come across, providing added safety and advantage in the wars. For athletes, wearable biosensors make it easy to keep track of their vitals during training. They can easily gain a competitive edge with biosensors designed to track their health and health and performance.

Creating a Proactive Healthcare Environment

The present-day healthcare system is more reactive than proactive. The patients only go to healthcare professionals after they show the symptoms of illness. While this might be more convenient for a lot of people, it is sometimes too late for the doctors to do anything about the illness. And that’s why using medical wearables can be a perfect way of changing the healthcare system into a proactive one so that the patients can be treated ahead of time.

With proactive healthcare systems, healthcare professionals can keep a close track of the patient’s health and act fast when any irregularities occur. This way the doctors can be prepared before any medical emergency makes the scenario even worse.

Easy Monitoring of the Patients

The emerging trend of wearables for mHealth applications has now made it easy for healthcare professionals to monitor the vitals of the patients. Sensors such as the ECG sensor, health patches are the perfect gadgets to monitor vulnerable patients in real-time.

Not only among the doctors but the popularity of these wearables are increasing among the common users too. Healthcare wearables are helping them immensely to take care of their ill family members by taking proactive measures when any kind of irregularities occur in their vitals. These sensors are also perfect for those who’ve had serious surgery. The medical services providers can track their recovery even when they are at home. This way the patients don’t have to spend a whole lot of time in the hospital for recovery.

Source: https://bdaily.co.uk/articles/2020/02/20/wearables-for-mhealth-apps-the-future-of-the-healthcare-industry

Indian VC industry sees record $10 billion investment in 2019 #Edtech SPONSOR: BetterU Education Corp. $BTRU.ca $ARCL $CPLA $BPI $FC.ca

Posted by AGORACOM-JC at 2:43 PM on Monday, March 2nd, 2020
SPONSOR:  BetterU Education Corp. aims to provide access to quality education from around the world. The company plans to bridge the prevailing gap in the education and job industry and enhance the lives of its prospective learners by developing an integrated ecosystem. Click here for more information.

Indian VC industry sees record $10 billion investment in 2019: Report

The amount was 55 per cent higher than the money invested by the industry in 2018, the report by Bain & Company’s India Venture Capital Report 2020 said. At the current exchange rate, USD 10 billion translates to over Rs 72,000 crore.

  • VC exit momentum in 2019 was in line with 2018, with secondary sales leading the mode of exits in India with an average exit value of around USD 39 million

The Indian venture capital industry invested record USD 10 billion in 2019, driven by increased deal volume and larger average deal sizes, according to a report. The amount was 55 per cent higher than the money invested by the industry in 2018, the report by Bain & Company’s India Venture Capital Report 2020 said. At the current exchange rate, USD 10 billion translates to over Rs 72,000 crore.

The report, in partnership with Indian Private Equity & Venture Capital Association (IVCA), said there has been 30 per cent increase in deal volume and 20 per cent rise in average deal size in 2019 over the previous year. “Despite substantial capital deployment, dry powder availability for VC investing in India was at an all-time high of USD 7 billion at the end of 2019, indicating likely continued investment activity in 2020,” it added.

The term ‘dry powder’ refers to cash reserves kept on hand by a company, venture capital firm or individual to cover future obligations. The VC exit momentum in 2019 was in line with 2018, with secondary sales leading the mode of exits in India with an average exit value of around USD 39 million. “Despite the global economic climate, India’s startup and VC ecosystems continue to thrive as investors take a long- term view based on the country’s growth potential. We go into 2020 with record-high levels of dry powder, counter-balanced with caution and an underlying optimism in the long-term potential for the ecosystem,” Arpan Sheth, Partner at Bain & Company, said.

About 80 per cent of the VC investments in 2019 was concentrated in four sectors — consumer tech, software/ SaaS, fintech and B2B commerce and tech. Consumer tech continued to be the largest sector, accounting for approximately 35 per cent of the total investments with several scale deals exceeding USD 150 million, the report said. Within consumer tech, verticalised e-commerce companies continued to be the largest sub-segment. In addition, there were increased investments in healthtech, foodtech and edtech as well.

“The Indian VC industry had a landmark year in 2019. However, India-focused VC investments raised less funds this year, the fundraising outlook for 2020 remains positive among both LPs and GPs (Limited Partners and General Partners),” Sriwatsan Krishnan, Partner at Bain & Company and co-author of the report, said. Following the brief moderation between 2015 and 2017, the VC industry in India has been in a renewed growth phase and that is expected to continue, Krishnan added.

The Indian startup ecosystem, one of the top five globally, continued to remain robust and grow rapidly. Between 2012 and 2019, the number of startups in India increased 17 per cent each year, while funded startups increased faster at 19 per cent CAGR in the same period, the report said. Currently, of almost 80,000 startups in India, only about 8 per cent are funded, indicating room for investments, it added. The report said India-focused VC funds raised about USD 2.1 billion in 2019, slightly lower than that in 2018.

The dip was the result of marquee funds that had already raised large sums and hence did not go to the market in 2019, it added. “There is a massive pipeline of soon to be unicorns; few of the Indian Unicorns will become decacorns by 2025. All this could not have happened without the support of the current government and the exits driven by first-generation entrepreneurs in the last couple of years,” IVCA President Rajat Tandon said.

Source: https://www.financialexpress.com/market/indian-vc-industry-sees-record-10-billion-investment-in-2019-report/1886543/

ZEN Graphene Solutions $ZEN.ca Announces the Launch of Graphene Product Sales $LLG.ca $FMS.ca $NGC.ca $CVE.ca $DNI.ca

Posted by AGORACOM at 9:53 AM on Monday, March 2nd, 2020

ZEN Graphene Solutions Ltd. (TSXV: ZEN) “ZEN” or the “Company“) is pleased to announce the launch of Albany Pure TM graphene products on their website at https://shop.zengraphene.com/. The Company is planning to expand its product line to bring Graphene Quantum Dots, Graphene Oxide, Reduced Graphene Oxide, and other graphene-based products to the market.

“We have reached a major milestone as our 2020 goal is to start bringing in revenue from the production and sale of Albany Pure TM graphene products,”  stated Francis Dubé, CEO. “Graphene is the new wonder material that is just beginning to be used in many large scale industrial applications and we are entering the graphene sales market at an optimal time.”

The Company is ramping up its new lab facility in Guelph, Ontario and is working towards larger-scale graphene production. The graphene precursor material is sourced from the unique, igneous-hosted Albany Graphite Deposit in Northern Ontario. As part of the company’s business development plan, ZEN is actively working with several industries to functionalize and test its graphene products in their applications with the potential for subsequent industry partnerships and agreements.

About ZEN Graphene Solutions Ltd.

ZEN is an emerging graphene technology solutions company with a focus on the development of graphene-based nanomaterial products and applications. The unique Albany Graphite Project provides the company with a potential competitive advantage in the graphene market as independent labs in Japan, UK, Israel, USA and Canada have independently demonstrated that ZEN’s Albany PureTM Graphite is an ideal precursor material which easily converts (exfoliates) to graphene, using a variety of mechanical, chemical and electrochemical methods.

For further information:

Dr. Francis Dubé, Chief Executive Officer
Tel: +1 (289) 821-2820
Email: [email protected]

AGORACOM Clients Attending PDAC 2020 $AFF.ca $AMK.ca $HPQ.ca $LMK.ca $NAM.ca

Posted by AGORACOM-JC at 4:32 PM on Friday, February 28th, 2020
Image result for PDAC 2020
AGORACOM Clients Attending PDAC 2020
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564657/hub/Affinity_Metals_Corp_Logo.png

THE REGAL PROJECT

B.C.’s Next Premier

Silver, Lead, Zinc, Copper Deposit?

Affinity Metals holds under option, a 100% interest in the Project, located within the northern end of the prolific Kootenay Arc, a highly prospective mineralized trend.

HIGHLIGHTS:

  • Massive geophysical targets for 2020
  • Past production
  • Historical reserves (non-43-101)
  • Access from Hwy 1 near Revelstoke

Booth Number 2751

Hub On AGORACOM

——————

Treaty Creeks’ GOLDSTORM zone hosts a conceptual volume of ONE BILLION TONNES rock grading close to one gram per tonne gold and is open to the north, east, and at depth.  

A major drill program is being planned for spring to develop a resource calculation. The focus has been on the gold enriched Goldstorm Zone which is on trend with, and part of, the same geological system as Seabridge Gold’s neighboring KSM deposits.

American Creek been selected to do a formal presentation at the conference. The presentation will be held on Tuesday, March 5 at 2:00PM in room #802

Booth Number 2351

Hub On AGORACOM

———————

Hpq large

HPQ Silicon Resources designs, develops, manufactures and commercializes plasma base processes

The innovative PUREVAP “Quartz Reduction Reactors” (QRR), will permit the One Step transformation of Quartz (SiO2) into High Purity Silicon (Si) at prices that will promote considerable renewable energy potential.

Booth Number 2145

Hub On AGORACOM


High Grade Flake Graphite

Lomiko hosts high-grade graphite at its La Loutre Property in Quebec. The company is working toward a Pre-Economic Assessment (PEA) that will increase its current indicated resource of 4.1 Mt of 6.5% Cg to over 10 Mt of 10%+ Cg in order to supply and develop graphite materials for the green economy.

Booth Number 2547

Hub On AGORACOM


New age large

River Valley Project is North America’s Largest Undeveloped Primary Platinum Group Metals (PGM) Deposit

Highlights:

  • 2.9 Million Ounces Palladium Equivalent in Measured plus indicated including an additional 1.1 Million Ounces Palladium Equivalent in Inferred
  • Positive PEA showing open pit potential with a life of mine of 14 years and annual average payable Palladium Equivalent production of 119,00 ounces
  • Life of mine average operating cash costs of US$709/Oz.
  • World class metallurgical facilities 100 km’s from project
  • To date the deepest drill hole was <600m, significant potential for more ounces located at depth
  • Average drill depth is 220 metres

Booth Number 2619B

Hub On AGORACOM

CLIENT FEATURE: Hollister Biosciences $HOLL.ca – Signed $20M LOI To Acquire Venom Extracts With $16.4M CAD In 2019 Revenue and 2.48M CAD in EBITDA $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 9:00 PM on Thursday, February 27th, 2020
HOLL:CSE /HOB:FRA

BREAKING: Signed $20,000,000 Letter of Intent To Acquire Venom Extracts (“Venom”)

HIGHLY ACCRETIVE $20,000,000 ACQUISITION

Venom Highlights

  • 2019 Est Revenue ~C$16.4M; EBITDA ~C$2.48M
  • 30% Of Acquisition Price Paid If Venom Revenues Hit $30,000,000 and $40,000,000 By DEC 31, 2021
  • Average revenue per gram YTD 2019 $CDN 14 and will continue to increase as vape cartridge mix grows ($CDN 30 per gram)
  • One Of Arizona’s Largest Producers Of Award-Winning Medical Cannabis Distillate
  • Acquisition Expected To Close By March 31, 2020 Subject To Due Diligence

An established brand in Arizona for high quality products in the wholesale and distillate marketplace. Venom is leveraging its brand and success to aggressively expand into other US states.

ACQUISITION TERMS

  • Hollister will acquire Venom Extracts for CDN$20,000,000 via Hollister stock
  • The stock price will be determined based on the greater of:
    • The 14-day VWAP (Volume Weighted Average Price) capped at $0.25 subsequent to announcing the transaction and $0.20
    • Once share price is established, 70% of the Payment Shares will be issued upon closing of the transaction
    • Remaining 30% of the Payment Shares will be issued when and if the following milestones have been met on or prior to December 31st, 2021

Per State Cash Flow Expectations

Planned State Additions

FIND OUT MORE!

Hub On AGORACOM / Corporate Profile / Read Release

FULL DISCLOSURE: Hollister Biosciences Inc. is an advertising client of AGORA Internet Relations Corp.

PyroGenesis $PYR.ca Announces New Website Launch $LMT $RTN $NOC $UTX $HPQ.ca $DDD.ca $SSYS $PRLB

Posted by AGORACOM-JC at 3:29 PM on Thursday, February 27th, 2020
  • Announced the launch of its redesigned website taking effect this March
  • Website has been revamped to include new features and improved functionality that provide instant access to essential information and features geared towards PyroGenesis’ interested parties 

MONTREAL, Feb. 27, 2020 — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products, is proud to announce the launch of its redesigned website taking effect this March. The website has been revamped to include new features and improved functionality that provide instant access to essential information and features geared towards PyroGenesis’ interested parties.  

PyroGenesis’ new website will be continuously updated with business developments, events, company presentations, media mentions and press releases. Once launched, visitors are encouraged to explore the website and sign up for direct emails from the Company.

“We are happy to unveil our redesigned website which offers a clean and modern design providing a more comprehensive understanding of PyroGenesis’ technologies,” said Mr. P Peter Pascali, CEO and President of PyroGenesis. “We believe that this website will allow our visitors to have a very informative experience as we continue to grow and increase our market presence. I trust the timing of this news release is not lost on our readers.”

Of note, it is possible that, during this transition, PyroGenesis’ website may be under maintenance for a period up to 24 hours. It is also important to note that, during the weeks following the launch date, the redesigned website may be experiencing some minor technical adjustments. PyroGenesis’ team will work diligently to ensure all issues are resolved in a timely manner. The company looks forward to hearing your comments and feedback.

About PyroGenesis Canada Inc.

PyroGenesis Canada Inc., a high-tech company, is the world leader in the design, development, manufacture and commercialization of advanced plasma processes and products. We provide engineering and manufacturing expertise, cutting-edge contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, advanced materials (including 3D printing), oil & gas, and environmental industries. With a team of experienced engineers, scientists and technicians working out of our Montreal office and our 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. Our core competencies allow PyroGenesis to lead the way in providing innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. Our operations are ISO 9001:2015 and AS9100D certified, and have been since 1997. PyroGenesis is a publicly-traded Canadian Corporation on the TSX Venture Exchange (Ticker Symbol: PYR) and on the OTCQB Marketplace. For more information, please visit www.pyrogenesis.com

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward- looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Corporation’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Corporation with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Corporation’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to publicly update or revise any forward- looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws. Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the OTCQB accepts responsibility for the adequacy or accuracy of this press release.

SOURCE PyroGenesis Canada Inc.

For further information please contact:

Rodayna Kafal, Vice President Investors Relations and Strategic Business Development
Phone: (514) 937-0002, E-mail: [email protected] 

RELATED LINK: http://www.pyrogenesis.com/

Empower Clinics $CBDT.ca – CBD consumption to rise across the treatment of neurological conditions $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 1:53 PM on Thursday, February 27th, 2020

SPONSOR:

Why Empower Clinics

  • A leading owner/operator of physician staffed health and pain management clinics.
  • Patient database of over 165,000 patients 
  • Platform generating $1.4M USD (9 months ending Sept. 30, 2019)
  • Proprietary technology platforms including Electronic Health Records portal and e-Commerce for CBD product distribution
  • Recently launched CBD extraction facility
  • First extraction system capacity = 2,300 Kg per year.
  • CBD based products are poised to be a $20B global industry by 2022
  • Medical cannabis is poised to be a $100B global industry by 2025
  • Company to Create Psilocybin and Psychadelics Division Leveraging Corporate Wellness Clinics and Franchise Clinic Network

CBD consumption to rise across the treatment of neurological conditions

Research shows that CBD consumption for the treatment of neurological conditions is set to rise.

  • With an exponential rise in the availability of CBD products and public opinion towards it becoming more positive over the past decade, the consumption of the ingredient has exploded.
  • Global Market Insights, Inc., forecasts that global cannabidiol market size will be worth more than $89bn by 2026.

By: Health Europa

However, the industry will need to overcome the complex regulatory landscape as well as quality and supply challenges in the near future.

Over the past few years, cannabidiol, or CBD, has caught the public’s imagination as an ingredient presenting a range of health benefits when infused in various consumables. More and more individuals worldwide are now vouching for its effectiveness in terms of alleviating certain chronic illnesses and treating several health conditions.

CBD has conquered industry after industry, from pharmaceuticals to personal care and cosmetics, food and beverages, and nutraceuticals.

Cannabidiol is the legal and non-psychoactive counterpart of tetrahydro cannabidiol (THC), the chemical compound responsible for cannabis’s psychological effects. CBD is the second most-commonly used active ingredients of cannabis. The cannabinoid is derived directly from the hemp plant, a cousin of the cannabis plant, and forms an essential component of medical cannabis.

CBD regulatory landscape in Europe

Factors such as population growth, nationalised healthcare, GDP, and cultural historic use of CBD in many European countries make the continent an attractive market for global producers of both medical and retail cannabis-based products. Hemp cultivation in the region has witnessed a massive upsurge in recent years; the European Union (EU) constitutes more than 25% of the global hemp production.

In July last year Epidiolex CBD oil received a positive recommendation for marketing approval from the European Medicines Agency (EMA) for the treatment of seizures. EMA’s Human Medicines Committee (CHMP) approved the oral solution for use with clobazam for the treatment of seizures associated with Dravet syndrome or Lennox-Gastaut syndrome in patients aged two or more.

The European Commission granted marketing approval to Epidyolex, the trade name for Epidiolex in Europe, in September 2019. Epidiolex is the only federally-approved CBD product in the U.S.

Additionally, the use of CBD in cosmetics is harmonised within the European Cosmetic Regulation 1223/2009. The regulation prohibits the use of cannabis and its derivatives in cosmetic products. Essentially, EU prohibits the use of CBD derived naturally from cannabis plants. However, the use of hemp-derived or synthetically-produced cannabidiol is approved.

Europe CBD market is poised to witness monumental growth in the forthcoming years on account of surging consumer demand for safe-strength CBD products that are easily available in their normal retail environments and cultivated, extracted, processed and labelled as per the European standards.

Growing burden of neurological diseases in Europe

Europe has witnessed a growing occurrence of various neurological conditions in recent years. These include epilepsy, migraine, stress, anxiety, and numerous sleeping disorders. An expanding geriatric population base indicates rising incidences of these conditions. Citing data from the European Brain Council, more than 220 million people in Europe suffer from at least one neurological condition, which is more than the populations of France, Germany, and the Great Britain combined.

Described below are some of the most prevalent neurological conditions in Europe and the effectiveness of CBD in their treatment.

  • Stress and anxiety – Nearly 25% of the European population suffers from stress, anxiety or depression each year. The effectiveness of CBD products as anti-anxiety nutraceuticals is backed with plenty of research, however there is still a long way to go. Several clinical trials have provided considerable evidence of cannabidiol’s usefulness for the treatment of generalised anxiety disorder (GAD), post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), social anxiety disorder, and panic disorder;
  • Migraine – Migraine currently affects more than 11% of the global population. The social societal burden of migraine in Europe is an approximately €27bn per year. While pain medications are known to help temporarily alleviate the symptoms of migraine, they can have several side-effects. Research concerning the use of cannabidiol for migraine is limited however a number of laboratory studies suggest that CBD oil may help reduce all types of acute and chronic pain, including migraine; and
  • Seizures – In Europe, close to six. million people suffer from epilepsy, while 15 million people will have at least one seizure at some point during their lifetime. Numerous research studies over the years have demonstrated the benefits and effectiveness of hemp-derived CBD products in patients with epilepsy who have not responded to traditional treatment.

Surging popularity of cannabidiol among boomers along with ongoing research and development into its potential health benefits will augment CBD market forecast. More and more boomers are adding CBD to their health regimes to help reduce stress and anxiety, get better sleep, and alleviate chronic pain. Increasing awareness towards the safety and efficacy of cannabidiol products will drive future CBD industry trends.

Source: https://www.healtheuropa.eu/cbd-consumption-to-rise-across-the-treatment-of-neurological-conditions/98105/

American Creek Resources $AMK.ca Drills Multiple High-Grade Polymetallic Zones Including 3.6m of 19.4 G/t AuEq at Dunwell Project in B.C.’s Golden Triangle $TUD.ca $SII.ca $GTT.ca $AFF.ca $SEA.ca $SA $PVG.ca $AOT.ca

Posted by AGORACOM at 9:21 AM on Thursday, February 27th, 2020

Cardston, Alberta–(February 27, 2020) – American Creek Resources Ltd. (TSXV: AMK) (“the Corporation”) is pleased to report the assays from phase 1 drilling from the 2019 fall drill program that was conducted at the company’s 100% owned Dunwell Mine property located in the Golden Triangle of British Columbia.

The Dunwell Mine is a high-grade past producing polymetallic mine located just 8km by road from the shipping town of Stewart. This property boasts exceptional logistics and a rich mining history with significant potential for future development. A significant geological feature running through the property is the Portland Canal Fissure Zone. With the recent acquisition of the Glacier Creek claims American Creek now controls 5km of the 6.5km Portland Canal Fissure Zone which contains numerous high-grade polymetallic mineral occurrences including two past producing mines (the Dunwell and Portland Canal). Very little modern exploration has been done on the property. While there is huge potential exploring along the extended reaches of the fissure zone, the initial drill program was designed to test areas near the workings of the Dunwell mine itself.

The initial objective for the drill program was to test the down dip extension of the Dunwell main vein below sub-level 4. The second objective was to test geophysical anomalies from an Induced Polarization (IP) survey conducted later in the fall of 2019. Both of these objectives were successfully accomplished with this drill program.

A total of 20 holes totaling 3,245.9m were completed on the property. The first 14 holes were based on geological and historical data and were successful in encountering veins of high-grade polymetallic mineralization including 20.3 g/t AuEq over 2.7m, 18.4 g/t AuEq over 1.5m, 28.6 g/t AuEq over 0.5m and 24.4 g/t AuEq over 0.5m.

Holes DW19-04 to DW19-08 were drilled to test the down dip of the Dunwell zone below sub-level 4.

HOLE FROM
(m)
TO
(m)
INTERVAL
(m)
AU
g/t
AG
g/t
CU
%
PB
%
ZN
%
AuEq
g/t
DW19-0486.2687.261.002.24217.80.0360.4071.0003.703
DW19-0521.2921.640.359.82865.80.0702.7703.28013.236
DW19-0626.9327.730.801.96536.50.0660.4672.1903.617
DW19-0726.2726.770.502.30526.70.0710.5212.6704.076
DW19-0782.1482.790.653.11425.60.0090.0680.6943.76
DW19-0826.4527.130.683.95941.00.0700.9493.7106.524
DW19-0889.2590.170.921.5516.70.0010.0210.0501.663

*AuEq uses $1,500 gold, $18 silver, $0.88 lead, $0.95 Zinc and $2.5 copper

Results show high-grade hits, including 13.2 g/t AuEq, in this series of holes that traversed from the east southeast to the east. The holes consistently hit two zones, both at the base of dikes at 22 – 26 meters and 83 – 87 meters. These two zones, seen in the five holes, run sub-parallel to the fault the drill pad was located on and trend for some distance to the north.

Hole DW19-09 was drilled to test the north extension of the main zone below level 4. The first breccia below the dike shows up in this hole with a 28.5 g/t AuEq assay and the second with a 18.4 g/t AuEq assay.

HOLE FROM
(m)
TO
(m)
INTERVAL
(m)
AU
g/t
AG
g/t
CU
%
PB
%
ZN
%
AuEq
g/t
DW19-0927.6028.050.4513.870258.00.43815.53011.04028.509
DW19-09143.02144.521.507.89884.90.3590.79120.25018.440

Hole DW19-10 was drilled to test below sub-level 4 but further to the southeast from hole DW19-04.

HOLE FROM
(m)
TO
(m)
INTERVAL
(m)
AU
g/t
AG
g/t
CU
%
PB
%
ZN
%
AuEq
g/t
DW19-1029.0029.570.572.78542.50.0550.7133.0204.956
DW19-1088.7189.610.903.53543.20.0601.4802.8605.959
DW19-1099.1399.790.661.70733.70.0310.2850.5292.491

The two breccias below the dikes, seen in holes 7 and 8 are present.

Holes 11 to 13 were drilled to follow up on the results from hole 9. The holes were drilled in a fan where holes 11 and 12 were drilled at a steeper angle to test below hole 9 and hole 13 was drilled at a flatter angle to test above hole 9. Hole 14 was drilled at a 5° rotation to the north of hole 9 to test the width of the structure.

HOLE FROM
(m)
TO
(m)
INTERVAL
(m)
AU
g/t
AG
g/t
CU
%
PB
%
ZN
%
AuEq
g/t
DW19-1126.8227.821.005.60166.00.2131.7007.85010.729
DW19-1195.6396.270.644.40834.50.0260.3630.7575.326
DW19-11138.45138.950.504.02666.00.1661.0706.2208.139
DW19-11142.24144.932.6911.346142.50.2203.19713.06920.269
DW19-1222.1723.471.302.85160.80.1471.8444.9466.638
DW19-1227.0527.810.761.56230.40.1040.6472.6603.461
DW19-1297.4999.151.661.54654.40.0411.0605.3564.998
DW19-1327.5528.150.608.110113.00.1714.6308.27015.116
DW19-13142.87143.570.704.48666.60.0680.7101.0096.087
DW19-1427.4328.230.808.924161.00.3095.1206.80016.222
DW19-1498.3299.861.547.69232.80.0090.2070.1118.227
DW19-14142.75144.701.953.72043.20.1030.7559.2408.673
DW19-14146.88147.380.509.403264.00.5285.21020.90024.347

All the holes intersected the breccia below the dike at about 27 meters. Holes 11, 13 and 14 appear to intersect a similar structure to that seen in hole 9. Multiple high-grade intercepts assayed as high as 24.3 g/t AuEq, 20.3 g/t AuEq, 16.3 AuEq, and 15.1 g/t AuEq while the remaining intercepts were still strong.

No modern exploration techniques or technologies have been used on the Dunwell until a cutting edge Induced Polarization (IP) survey took place in late fall of 2019. Only two of the dozens of geophysical anomalies identified in the survey in close proximity to the Dunwell Mine were drill tested in this first phase of drilling.

The last 6 holes (DW19-15 to DW19-19) were drilled to test the extent of a large IP anomaly and were successful in encountering veins of high-grade polymetallic mineralization including 19.4 g/t AuEq over 3.6m, 38.1 g/t AuEq over 0.5m and 28.4 AuEq over 0.4m with the remaining intercepts also containing significant mineralization.

Hole 15 was drilled south into the anomaly and Hole 16 was drilled west into the anomaly with both intersecting a massive sulphide zone. Holes 17 – 19 were drilled in a fan to follow up hole 16. Hole 18 also hit a massive sulphide zone.

HOLE FROM
(m)
TO
(m)
INTERVAL
(m)
AU
g/t
AG
g/t
CU
%
PB
%
ZN
%
AuEq
g/t
DW19-15100.90102.081.188.445869.00.0340.1861.26519.536
DW19-15152.09152.590.5032.230472.00.0080.1340.37238.119
DW19-1645.1145.810.7011.260144.00.2086.5506.01018.471
DW19-1675.0778.683.618.85088.80.2211.76819.51419.354
DW19-17 no significant results     
DW19-1838.7939.220.4315.300185.02.8742.87014.47028.243
DW19-1934.8736.041.173.33227.90.0480.9862.5805.239
DW19-1975.7177.131.425.255225.90.1599.2983.31513.328

Hole 16 hit a massive sulphide interval at 75 – 78 meters. Hole 20 was drilled to test an IP anomaly along the access road below the second drill pad. One small breccia was intercepted.

HOLE FROM
(m)
TO
(m)
INTERVAL
(m)
AU
g/t
AG
g/t
CU
%
PB
%
ZN
%
AuEq
g/t
DW19-20121.01121.450.441.66927.50.0070.0340.0822.056

CEO and President, Darren Blaney stated: “Our very first drill program has intersected a significant number of high-grade veins in the vicinity of the mine workings confirming our belief in the potential of this project.

The Dunwell is an incredibly prospective property located in the heart of the Golden Triangle. It has everything going for it from amazing logistics to past high-grade production, with all indications being that there is substantive additional ore yet to be mined.

With the recent acquisition of the Glacier Creek Crown Grants we now cover 5km of the heavily mineralized Portland Canal Fissure Zone which runs for 6.5km and is associated with over a dozen high-grade gold and silver showings including two past producing mines. The potential of the property extends far beyond the old workings of the Dunwell Mine. Future exploration will be using the latest technologies to aid us in unlocking that potential.”


Dunwell Mine Property Aerial Map

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/682/52888_602268149456990f_001full.jpg

Property Description and History

Through a series of strategic acquisitions American Creek was able to purchase the past-producing Dunwell Mine as well as several adjoining very prospective properties, combining them into one large land package that encompasses the best gold and silver mineral occurrences and historic workings in the Bear River valley. The amalgamated property spans 2,222 hectares covering the majority of the Portland Canal Fissure Zone, an area first prospected in the late 1800’s and hosting some of the earliest producing gold and silver mines in the Stewart area.

The Dunwell project is located 8km northeast of Stewart and is road accessible with the Dunwell Mine adit itself located only 2km from Highway 37A and a major power line. Stewart hosts a deep sea port including ore loading and shipping facilities. Unlike the majority of mineral properties located near Stewart, the Dunwell is located in low mountainous terrain (700 m and lower elevation) with moderate relief. These features allow for year-round work which typically isn’t the case for exploration programs conducted in the Stewart region where projects are typically at higher altitude, are accessible only by helicopter, and lack critical infrastructure such as roads and power. The Dunwell project may just have the best logistics of any project in the Golden Triangle.


Dunwell Mine Property Aerial Map

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/682/52888_602268149456990f_002full.jpg

The Dunwell Mine is the most significant mineral occurrence within the Portland Canal Fissure Zone. Production at the Dunwell occurred between 1926 and 1937. From historic reports, it appears that a total of 45,657 tonnes averaging 6.63 g/t gold, 223.91 g/t silver, 1.83% lead, 2.43% zinc and 0.056% copper were produced.

In addition to the Dunwell mine itself, the property package also contains over a dozen other high-grade gold and silver occurrences and historic small-scale gold/silver high-grading operations along a north/south trend that correlates to the fissure zone and major faulting. Some examples of the nine areas that actually produced ore are:

  • Ben Ali:                   4,500 tons at 21.6 g/t gold
  • Lakeview                60 tons at 4.7 g/t gold, 2,734 g/t silver, and 11.5% lead
  • Victoria                   11 tons at 20.15 g/t gold, 775 g/t silver, 25% lead
  • Tyee                       8.2 tons at 124.4 g/t gold and 4,478.8 g/t silver
  • George E               12 tons at 13 g/t gold and 3,250 g/t silver, 23.3% lead

Each of these areas were producing during the 1930’s when exploration techniques and technology was very primitive. American Creek has already started to use the latest in exploration technology on the property and will continue to do so to unlock the great potential that exists here.

For more information on the Dunwell Mine please click here:
https://americancreek.com/index.php/projects/dunwell-mine

Qualified Person

The Qualified Person for the Dunwell results in this new release is James A. McCrea, P. Geo., for the purposes of National Instrument 43-101. He has read and approved the scientific and technical information that forms the basis for the disclosure contained in this news release.

About American Creek

American Creek holds a strong portfolio of gold and silver properties in British Columbia. The portfolio includes three Golden Triangle gold/silver properties; the Treaty Creek and Electrum joint ventures with Walter Storm/Tudor as well as the 100% owned past-producing Dunwell Mine. Other properties held throughout BC include the Gold Hill, Austruck-Bonanza, Ample Goldmax, Silver Side, and Glitter King.

For further information please contact Kelvin Burton at: Phone: 403 752-4040 or Email: [email protected]. Information relating to the Corporation is available on its website at www.americancreek.com

#KABN NA Proposed RTO / Public Listing Update

Posted by AGORACOM-JC at 9:18 AM on Thursday, February 27th, 2020

KABN Systems North America Inc. A Fintech platform focused on Verifying, Managing & Monetizing Online Identity. KABN’s mission is to create a world-class suite of products and services that support the decentralized market economy, globally enabling consumers to manage their digital identity and other data to create value-based relationships in the financial and loyalty services arena.

FROM THE DESK OF DAVID LUCATCH, President, Co-Founder & Director :

Good Morning.

The Management Information Circular for the Business Combination (RTO) between KABN Systems North America Inc. and Torino Power Solutions Inc. (CSE:TPS) has been publicly filed on SEDAR.   

Torino Power Solution’s Annual and Special Meeting is scheduled to be held on March 31, 2020 at 10 am PST in Vancouver. 

To view the Management Information Circular, Please visit:

https://www.sedar.com/DisplayProfile.do?lang=EN&issuerType=03&issuerNo=00036995

Click on View This Company’s Documents at the bottom left 

Select: Management information circular – English 

Dated:  February 26, 2020  

Click on the item and enter the code and view.

Happy Reading and feel free to share!

In addition to accelerating KABN NA’s business activities, during this period, we will be working with the investment community and counsel to finalize the Listing Statement for the CSE.

KABN NA will be at FFCON20 – RISE

Don’t forget to get your ticket and visit us at the 6th Annual FFCON20 on March 23rd and 24th in Toronto – click here for your discount tickets https://bit.ly/2Pj64UZ 

As always, if you have any questions or comments, please feel free to reach out. 

My best,

David Lucatch

President, Co-Founder & Director

p: +1 416 409 4318

e: [email protected]

REPEAT: Mota Ventures $MOTA.ca Signs Letter of Intent for Merger with Stillcanna $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca $FAF.ca

Posted by AGORACOM at 9:10 AM on Thursday, February 27th, 2020
http://www.smallcapepicenter.com/Mota%20Square%20Logo%20For%20Blog.jpg
  • Stillcanna is a vertically integrated, European-based company with a focus on industrial-scale manufacturing of the highest quality CBD extracts
  • Stillcanna looks to become one of the largest producers of THC-free CBD extracts in Europe

VANCOUVER, BC / ACCESSWIRE / February 26, 2020 / Mota Ventures Corp. (CSE:MOTA)(OTC:PEMTF)(FRANKFURT:1WZGR) (“Mota“) and Stillcanna Inc. (STIL)(SCNNF)(A2PEWA) (“Stillcanna“) are pleased to announce that they have entered into a letter of intent (the “Letter of Intent“), dated effective February 25, 2020, pursuant to which Mota proposes to acquire all of the outstanding share capital of Stillcanna (the “Proposed Transaction“).

Strategic Merger

Mota is a globally-focused CBD product development and marketing company with established online retail brands in both the U.S. and Europe. Through its acquisition of First Class CBD, Mota has become a significant direct-to-consumer retail brand in the United States. In 2019, First Class CBD (then, a division of Unified Funding, LLC) realized approximately C$28.7 million in revenue with an EBITDA of approximately 12.5%.1 Mota’s successful e-commerce platform currently serves over 140,000 online customers and has generated over 400,000 leads in the United States. With the roll-out of First Class CBD’s proven e-marketing strategy throughout Europe, Mota believes that a merger with a high-quality CBD producer is of paramount importance in order to capture the large margins in the CBD-product supply chain.

Stillcanna is a vertically integrated, European-based company with a focus on industrial-scale manufacturing of the highest quality CBD extracts. Using proprietary extraction techniques and purpose-built equipment, Stillcanna looks to become one of the largest producers of THC-free CBD extracts in Europe. Stillcanna’s Polish extraction facility, NEXUS, features industrial-scale centrifugal chromatography equipment that allows for the production of bulk THC-free CBD distillate as well as custom Cannabinoid profiles. In February 2020, Stillcanna’s Romanian extraction facility, ORIGIN, which operates pursuant to a joint venture between Stillcanna and Dragonfly Biosciences Ltd., received approval from the Ministry of Health and the Anti-Drug Agency to become the first government recognized extraction facility in the country. To date C$23,000,000 has been invested by Stillcanna in the cultivation and extraction operations, with current cash on hand in Stillcanna of approximately C$7,000,000.

Stillcanna’s CBD extracts are key to unlocking additional value in Mota’s retail offerings in Europe. Through Stillcanna, Mota hopes to guarantee the supply of high-quality CBD for its expanding product line in Europe, while the large production capacity of NEXUS and ORIGIN will allow Mota to be a key supplier of legal CBD products in Europe.

“We are very excited to pursue a transaction with Stillcanna. The merger of this large-scale, high-quality CBD producer will fit brilliantly with Mota’s strategic expansion plan to vertically integrate operations in Europe while increasing profit margins in product offerings. Product awareness and availability are still quite limited in Europe, which presents an opportunity for Mota to further establish its brands in a market that is expected to experience rapid growth in the near term. With the Stillcanna merger, we’re putting together a team that can create, market and sell consumer CBD products to European customers,” stated Ryan Hoggan, CEO of Mota.

“Combining a company that has established brands and direct-to-consumer sales channels with one that has proven CBD extraction expertise makes perfect sense to us,” commented Jason Dussault, CEO of Stillcanna. “The wholesale landscape for CBD has changed dramatically in the past year, and the creation of a seed-to-consumer CBD company in the growing European market creates a direct path to profitability. This merger completes the circle for Stillcanna, evolving from a seed to CBD concentrate company to a seed to retail sales company.”

Merger Details

Under the terms of the Proposed Transaction, Mota would acquire all of the outstanding share capital of Stillcanna by way of a statutory plan of arrangement under the Business Corporations Act of British Columbia Canada. Shareholders of Stillcanna (the “Stillcanna Shareholders“) would receive one common share of Mota for every 1.8 common shares of Stillcanna held at the time of exchange (the “Exchange Ratio“). Based on the current outstanding common share capital of Stillcanna, it is anticipated that Mota would issue approximately 61,597,082 Mota shares to complete the Proposed Transaction.

Upon completion of the Proposed Transaction: (i) all outstanding incentive stock options of Stillcanna will be exchanged for options to purchase Mota shares on the basis of the Exchange Ratio and will thereafter be subject to the incentive stock option plan of Mota; and (ii) all unexercised share purchase warrants of Stillcanna will be exchanged for warrants to purchase Mota shares on the basis of the Exchange Ratio and will expire in accordance with their current expiry dates.

Mota and Stillcanna are at arms-length. The Proposed Transaction does not constitute a reverse-takeover of Mota, nor is it expected to result in a change of control of Mota within the meaning of applicable securities laws and the policies of the Canadian Securities Exchange. Upon completion of the Proposed Transaction, there will be no changes to the management or the board of directors of Mota and it is expected that members of management and the board of Stillcanna will continue to assist in relation to the management of Stillcanna’s business.

Completion of the Proposed Transaction remains subject to a number of conditions, including, but not limited to: (i) satisfactory completion of due diligence; (ii) negotiation of definitive, legally-binding documentation; (iii) receipt of any required regulatory approvals, including the court; (iv) the approval of the Stillcanna Shareholders; (v) receipt of a satisfactory fairness opinion in respect of the Proposed Transaction; (vi) Stillcanna having arranged to amend the terms of certain existing employment and consulting engagements; (vii) shareholders of Stillcanna holding at least 40,000,000 of the outstanding share capital of Stillcanna having agreed to the terms of a pooling arrangement restricting their ability to trade one-half of the Mota shares they receive for a period of six months following completion of the Proposed Transaction; (viii) Stillcanna having positive working capital of not less than C$6,000,000, after taking into account all expenses associated with the Proposed Transaction; and (ix) Mota completing a private placement of units to raise gross proceeds of not less than C$5,000,000 (the “Mota Financing“). The Proposed Transaction cannot be completed until these conditions are satisfied. There can be no assurance that the Proposed Transaction will be completed as proposed or at all.

The proposed Mota Financing will consist of units at a price of C$0.45 per unit, with each unit comprised of one Mota common share and one share purchase warrant of Mota. Each such warrant will be exercisable to purchase one common share of Mota at a price of C$0.60 for a period of two years. All securities to be issued in connection with the Mota Financing will be subject to a four-month-and-one-day statutory hold period in accordance with applicable securities laws. Mota anticipates paying finders fees to certain eligible parties who have introduced subscribers to the Mota Financing.

The board of directors of each of Mota, and Stillcanna, have unanimously approved the Letter of Intent. Further information about the Proposed Transaction will be included in subsequent press releases when available.

About Mota Ventures Corp.

Mota is seeking to become a vertically integrated global CBD brand. Its plan is to cultivate and extract CBD into high-quality value-added products from its Latin American operations and distribute it both domestically and internationally. Its existing operations in Colombia consist of a 2.5-hectare site that has optimal year-round growing conditions and access to all necessary infrastructure. Mota is looking to establish sales channels and a distribution network internationally through the acquisition of the Sativida and First Class CBD brands. Low cost production, coupled with international, direct to customer sales channels will provide the foundation for the success of Mota.

About Stillcanna Inc.

Stillcanna is a Canadian early-stage life sciences company focused on the large-scale manufacturing of CBD in Europe using its proprietary intellectual property. Stillcanna has signed an initial extraction contract in Europe to be the exclusive extractor for Dragonfly Biosciences LLC, a United Kingdom-based supplier of CBD. Stillcanna also recently completed the acquisition of Olimax NT SP.Z.O.O., a multi-generational hemp agricultural firm that is expected to increase market share in the European CBD industry.

On behalf of Mota Ventures Corp.

Ryan Hoggan
Chief Executive Officer

On behalf of Stillcanna Inc.

Jason Dussault

Chief Executive Officer

For more information visit

www.motaventuresco.com or contact:

Investor Relations

[email protected]
+1.604.423.4733

For more information visit www.stillcanna.com or contact:

Mauricio Inzunza
[email protected]